SS Innovations International Inc. (NASDAQ: SSII) has supported the launch of Sri Lanka's first robotic cardiac surgery program at Kings Hospital Colombo, using the SSi Mantra 3.0 surgical robotic system. This development represents a notable step in the adoption of robotic-assisted cardiac procedures in South Asia and underscores the growing global footprint of SS Innovations' technology.
The program commenced with a robotic-assisted left internal mammary artery (LIMA) takedown, performed by Dr. Sudhir Srivastava, founder and chairman of SS Innovations, alongside Kings Hospital cardiothoracic surgeon Dr. Rajitha DeSilva. This initial procedure demonstrates the feasibility and potential of robotic systems in complex cardiac surgeries, which traditionally require high precision and minimal invasiveness.
According to a recent company video describing the program's early activity, Kings Hospital has completed more than 25 robotic procedures in just three weeks. This rapid uptake suggests strong local interest and confidence in the SSi Mantra system, and it may encourage other hospitals in the region to adopt similar robotic programs.
SS Innovations reported 224 cumulative SSi Mantra installations across 12 countries at the end of the second quarter. The company's second-quarter revenue reached $13.9 million, while robotic procedures increased 143% year over year to 2,528. These figures point to rising utilization of the company's installed base, as more surgeons and hospitals integrate the system into their practices. The expansion into Sri Lanka adds another country to SS Innovations' growing list of markets and could serve as a catalyst for further adoption in neighboring nations.
The next major corporate milestone is regulatory expansion, with SS Innovations pursuing U.S. FDA clearance and European CE marking for the SSi Mantra system. Achieving these certifications would allow the company to enter two of the world's largest and most regulated healthcare markets, potentially driving significant revenue growth and further validating its technology on a global scale.
For investors, the launch of the Sri Lanka program and the company's strong procedure growth highlight the commercial momentum behind SS Innovations. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII. As robotic surgery continues to gain traction worldwide, SS Innovations' ability to secure new markets and expand its installed base will be key to its long-term success.
